Key Highlights
- Orthobond appoints Eric Major as Chairman of the Board.
- Major brings over 30 years of industry experience.
- Orthobond recently received FDA clearance for their anti-bacterial solution.
Source: Business Wire
Notable Quotes
- “Eric’s impressive career, spanning over three decades in the industry, is a testament to his extensive expertise and visionary leadership.” — Frank Cammisa, MD, Chief Emeritus of HSS Spine at Hospital for Special Surgery, CMO and Board Member at Orthobond
- “We are pleased to be expanding Orthobond’s Board of Directors with the appointment of Eric, whose vast experience in the medical device space and in driving strategic growth will be an instrumental part of Orthobond’s future.” — David Nichols, CEO at Orthobond
- “Orthobond’s antibacterial technology is a true breakthrough for patient care in the medical device space and the recent FDA clearance allows for a new and exciting chapter for the company.” — Eric Major, Chairman of the Board at Orthobond Corporation
SoHC's Take
The appointment of Eric Major as Chairman of Orthobond Corporation marks a significant strategic move for the company. Major’s extensive background in the medical device industry, combined with his proven track record in steering both public and private enterprises towards growth, positions Orthobond to leverage his expertise in navigating the commercial phase of their groundbreaking antibacterial technology. With recent FDA clearance for their non-drug eluting solution, Orthobond is poised to make substantial advancements in patient care and market penetration. Major’s leadership is expected to drive innovation and strategic growth, reinforcing Orthobond’s commitment to excellence in antibacterial surface technologies.
